Financials NIOX Group Plc

Equities

CIR

GB00BJVD3B28

Pharmaceuticals

Market Closed - London S.E. 11:35:28 2024-07-12 am EDT 5-day change 1st Jan Change
66.8 GBX -4.57% Intraday chart for NIOX Group Plc -3.19% -0.30%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 71.18 111.9 169.6 153.1 281.9 283.3 - -
Enterprise Value (EV) 1 156.2 104.5 158.3 134.7 263.1 255.4 246.8 236.2
P/E ratio -1.46 x - 40.6 x 10.1 x 28.2 x 24.3 x 20.8 x 18.5 x
Yield - - - - 1.49% 1.66% 2.19% 2.2%
Capitalization / Revenue 1.14 x 2.43 x 6.08 x 4.89 x 7.66 x 6.68 x 5.93 x 5.32 x
EV / Revenue 2.5 x 2.27 x 5.67 x 4.3 x 7.15 x 6.03 x 5.17 x 4.44 x
EV / EBITDA -5.62 x -9.42 x 264 x 18.5 x 23.1 x 18.5 x 15 x 12.7 x
EV / FCF -4.46 x - 122 x 20.4 x 22.9 x 17.8 x 17.6 x 14.2 x
FCF Yield -22.4% - 0.82% 4.9% 4.37% 5.62% 5.69% 7.05%
Price to Book 0.84 x - 2.54 x 1.87 x 3.59 x 3.13 x 2.86 x 2.69 x
Nbr of stocks (in thousands) 374,655 396,836 417,684 419,504 420,684 424,045 - -
Reference price 2 0.1900 0.2820 0.4060 0.3650 0.6700 0.6680 0.6680 0.6680
Announcement Date 6/16/20 3/24/21 3/22/22 3/21/23 3/26/24 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 62.4 46 27.9 31.3 36.8 42.38 47.73 53.23
EBITDA 1 -27.8 -11.1 0.6 7.3 11.4 13.77 16.42 18.53
EBIT 1 -43 -17.3 -4.3 1.8 4.6 8.72 11.06 13.14
Operating Margin -68.91% -37.61% -15.41% 5.75% 12.5% 20.58% 23.17% 24.68%
Earnings before Tax (EBT) 1 -59.1 -18.4 -2.1 10.5 4.1 8.287 10.72 12.86
Net income 1 -48.3 - 3.6 16.1 10.7 12.53 14.64 16.5
Net margin -77.4% - 12.9% 51.44% 29.08% 29.57% 30.68% 31%
EPS 2 -0.1300 - 0.0100 0.0363 0.0238 0.0275 0.0322 0.0362
Free Cash Flow 1 -35 - 1.3 6.6 11.5 14.36 14.04 16.64
FCF margin -56.09% - 4.66% 21.09% 31.25% 33.89% 29.41% 31.27%
FCF Conversion (EBITDA) - - 216.67% 90.41% 100.88% 104.3% 85.53% 89.81%
FCF Conversion (Net income) - - 36.11% 40.99% 107.48% 114.63% 95.87% 100.88%
Dividend per Share 2 - - - - 0.0100 0.0111 0.0146 0.0147
Announcement Date 6/16/20 3/24/21 3/22/22 3/21/23 3/26/24 - - -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 85 - - - - - - -
Net Cash position 1 - 7.4 11.3 18.4 18.8 27.8 36.5 47.1
Leverage (Debt/EBITDA) -3.058 x - - - - - - -
Free Cash Flow 1 -35 - 1.3 6.6 11.5 14.4 14 16.6
ROE (net income / shareholders' equity) -45.8% - - 21.7% 12.9% 13.9% 14.7% 14.9%
ROA (Net income/ Total Assets) - - - - - 12.9% 13.8% 14.7%
Assets 1 - - - - - 97.5 105.8 112
Book Value Per Share 2 0.2300 - 0.1600 0.2000 0.1900 0.2100 0.2300 0.2500
Cash Flow per Share 2 - -0.0600 0 - - 0.0300 0.0300 0.0400
Capex 1 10.3 - - 0.1 0.1 1.05 0.55 0.35
Capex / Sales 16.51% - - 0.32% 0.27% 2.48% 1.15% 0.66%
Announcement Date 6/16/20 3/24/21 3/22/22 3/21/23 3/26/24 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.668 GBP
Average target price
0.7825 GBP
Spread / Average Target
+17.14%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CIR Stock
  4. Financials NIOX Group Plc